Researchers identify gene mutations linked to bipolar disorder, potentially leading to new treatments.

Researchers have found rare genetic mutations in the HECTD2 and AKAP11 genes that increase the risk of developing bipolar disorder. These genes are involved in cellular processes and interact with a protein inhibited by lithium, a common treatment for bipolar disorder. The discovery could lead to better diagnostic methods and new treatments for the condition, which is characterized by extreme mood swings.